Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 450.96M | -2.3x | -1.45 | EUR 7.06 | -5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Valneva | Paris | Healthcare | Biotechnology & Medical Research | EUR 312.89M | -35.5x | -0.43 | EUR 1.92 | -4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurobio Scientific | Paris | Healthcare | Biotechnology & Medical Research | EUR 254.10M | 42.1x | -1.71 | EUR 25.30 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.6% Upside | Upgrade to Pro+ | |
Inventiva | Paris | Healthcare | Biotechnology & Medical Research | EUR 190.70M | -1.1x | 0.22 | EUR 2.19 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sensorion SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 188.03M | -6x | -0.13 | EUR 0.63 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genfit | Paris | Healthcare | Biotechnology & Medical Research | EUR 176.72M | 7.9x | 0.05 | EUR 3.46 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Innate Pharma | Paris | Healthcare | Biotechnology & Medical Research | EUR 158.57M | -4.6x | -0.1 | EUR 1.92 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 153.58M | 3.2x | 0.02 | EUR 7.06 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | EUR 151.70M | -4.1x | -0.09 | EUR 3.20 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellectis | Paris | Healthcare | Biotechnology & Medical Research | EUR 149.14M | -1.5x | -0.06 | EUR 1.49 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Maat Pharma | Paris | Healthcare | Biotechnology & Medical Research | EUR 111.35M | -3.7x | 0.11 | EUR 7.88 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurofins-Cerep | Paris | Healthcare | Biotechnology & Medical Research | EUR 100.88M | 10.3x | EUR 20,000 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Transgene | Paris | Healthcare | Biotechnology & Medical Research | EUR 92.53M | -3.1x | -0.13 | EUR 0.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Adocia | Paris | Healthcare | Biotechnology & Medical Research | EUR 90.14M | -3.9x | -0.15 | EUR 5.80 | -7.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.6% Upside | Upgrade to Pro+ | |
Novacyt | Paris | Healthcare | Biotechnology & Medical Research | EUR 43.67M | -1x | 0.02 | EUR 0.61 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abionyx Pharma SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 42.72M | -11.5x | -0.58 | EUR 1.24 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genoway | Paris | Healthcare | Biotechnology & Medical Research | EUR 34.51M | 22.7x | EUR 3.83 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Gensight Biologics | Paris | Healthcare | Biotechnology & Medical Research | EUR 32.24M | -0.9x | -0.04 | EUR 0.28 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.5% Upside | Upgrade to Pro+ | |
Fermentalg | Paris | Healthcare | Biotechnology & Medical Research | EUR 30.10M | -1.3x | 0.14 | EUR 0.35 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Valbiotis | Paris | Healthcare | Biotechnology & Medical Research | EUR 21.75M | -2.2x | -0.11 | EUR 1.35 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NFL Biosciences | Paris | Healthcare | Biotechnology & Medical Research | EUR 17.96M | EUR 1.77 | -4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Oncodesign Precision Medicine | Paris | Healthcare | Biotechnology & Medical Research | EUR 17.66M | -2.3x | EUR 0.75 | -22.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Phaxiam Therapeutics | Paris | Healthcare | Biotechnology & Medical Research | EUR 17.22M | -0.3x | EUR 1.72 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Institut Biophytis SAS | Paris | Healthcare | Biotechnology & Medical Research | EUR 15.31M | -0.5x | -0 | EUR 0.34 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Predilife | Paris | Healthcare | Biotechnology & Medical Research | EUR 13.53M | -2.9x | 0.18 | EUR 3.64 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Plant Advanced Technologies SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 12.52M | -18.7x | EUR 11.30 | -4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Poxel SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 6.93M | -0.1x | EUR 0.13 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Quantum Genomics SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 5.03M | -0.5x | -0.01 | EUR 0.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.7% Upside | Upgrade to Pro+ | |
Theranexus | Paris | Healthcare | Biotechnology & Medical Research | EUR 4.45M | -1.5x | -0.02 | EUR 0.58 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acticor Biotech | Paris | Healthcare | Biotechnology & Medical Research | EUR 3.92M | -0.2x | -0.01 | EUR 0.25 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |